Alkem Laboratories
Alkem Laboratories is an Indian pharmaceutical company that specializes in the development, manufacture, and sale of a wide range of pharmaceutical products, including branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals. The company focuses on both acute and chronic therapeutic areas, offering products for conditions such as infections, pain management, cardiovascular issues, diabetes, gynecology, neurology, dermatology, and osteoporosis. Alkem has established a significant presence in the Indian market and also exports its products to countries including the United States, Australia, and the United Kingdom. With over a decade among the top ten pharmaceutical companies in India, Alkem Laboratories continues to expand its reach and product offerings in both domestic and international markets.
4 past transactions
Adroit Biomed
Acquisition in 2025
Adroit Biomed specializes in dermato-cosmetology and offers excellent quality medicines that drive meaningful change in dermatology.
Enzene Biosciences
Venture Round in 2023
Enzene Biosciences is a biotechnology company focused on providing affordable medicines through the development of biosimilars. The company leverages advanced technologies and sophisticated analytics within its state-of-the-art manufacturing facilities to ensure cost-effective production. Enzene specializes in cloning, process development, and novel formulation development, enabling clients in the microbial manufacturing sector to adopt innovative solutions that improve healthcare outcomes. Additionally, the company aims to expand its reach and impact by forming strategic global alliances, while fostering a distinctive work culture that positions it as a desirable employer in the biotech industry.
Eyestem
Series A in 2022
Eyestem is a cell therapy company focused on developing scalable cell replacement therapies for incurable diseases, particularly targeting conditions like age-related macular degeneration (Dry AMD). Founded by a team of experts in clinical trials, cell therapy, and ophthalmology, Eyestem aims to create a robust and consistent cell therapy platform that prioritizes both efficacy and safety. The company is committed to democratizing access to advanced cell therapies, ensuring that these innovative treatments are available to a global population. By collaborating with leaders in the field, Eyestem seeks to drive advancements in cell therapy, enhancing the potential for effective treatments for various debilitating conditions.
Zapkey
Seed Round in 2022
Zapkey is a proptech company focused on streamlining the buying and selling of real estate. It offers a unique home sales guarantee, ensuring that customers will sell their property within three months of listing. If the sale does not occur within this timeframe, Zapkey commits to purchasing the property at a fair market price, determined through data algorithms. This approach aims to provide transparency and fairness in the property sales process, enhancing the overall experience for sellers and buyers alike. Through its platform, Zapkey seeks to address common challenges in real estate transactions while fostering confidence among its customers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.